Publikationen von I. Sillaber

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Droste, S.; Reul, J. H. M. H.; Holsboer, F.; Wurst, W.: Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. European Neuropsychopharmacology 14 (Suppl. 1), S. S27 - S28 (2004)

Sillaber, I.; Henniger, M. S.: Stress and alcohol drinking. Annals of Medicine 36 (8), S. 596 - 605 (2004)

Erhardt, A.; Welt, T.; Schmidt, W.; Sillaber, I.; Keck, M. E.: Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry 36 (5), S. 223 - 224 (2003)

Henniger, M. S. H.; Sillaber, I.: Choosing the right black mice - a matter of particular importance! Pharmacopsychiatry 36 (5), S. 232 - 232 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J.; Droste, S.; Reul, J. H. M. H.; Holsboer, F.; Wurst, W.: Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. Pharmacopsychiatry 36 (5), S. 249 - 249 (2003)

Sillaber, I.; Ohl, F.; Bartl, C.; Panhuysen, M.; Henniger, M. S. H.; Holsboer, F.: Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants. Pharmacopsychiatry 36 (5), S. 265 - 265 (2003)

Deroche-Gamonet, V.; Sillaber, I.; Aouizerate, B.; Izawa, R.; Jaber, M.; Ghozland, S.; Kellendonk, C.; Le Moal, M.; Spanagel, R.; Schutz, G. et al.; Tronche, F.; Piazza, P. V.: The glucocorticoid receptor as a potential target to reduce cocaine abuse. Journal of Neuroscience 23 (11), S. 4785 - 4790 (2003)

Brodski, C.; Weisenhorn, D. M. V.; Signore, M.; Sillaber, I.; Oesterheld, M.; Broccoli, V.; Acampora, D.; Simeone, A.; Wurst, W.: Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the midbrain hindbrain organizer. Journal of Neuroscience 23 (10), S. 4199 - 4207 (2003)

Brodski, C.; Weisenhorn, D. V.; Signore, M.; Naserke, T.; Fischer, T.; Sillaber, I.; Simeone, A.; Wurst, W.: Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the mid-hindbrain organizer. European Journal of Cell Biology 82 (Suppl. 53), S. 40 - 41 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Timpl, P.; Kormann, M. S. D.; Droste, S. K.; Kühn, R.; Reul, J. M. H. M. et al.; Holsboer, F.; Wurst, W.: Limbic corticotropin-releasing hormone receptor I mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 6 (10), S. 1100 - 1107 (2003)

Sillaber, I.; Henniger, M. S. H.: Genetik und Drogensucht. BIOspektrum 8, S. 252 - 255 (2002)

Ohl, F.; Sillaber, I.; Binder, E.; Keck, M. E.; Holsboer, F.: Differential analysis of behavior and diazepam-induced alterations in C 57 BL/6 N and BALB/c mice using the modified hole board test. Journal of Psychiatric Research 35, S. 147 - 154 (2001)

Preil, J.; Müller, M. B.; Gesing, A.; Reul, J. M. H. M.; Sillaber, I.; van Gaalen, M. M.; Landgrebe, J.; Holsboer, F.; Stenzel-Poore, M.; Wurst, W.: Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142, S. 4946 - 4955 (2001)

Keck, M. E.; Sillaber, I.; Ebner, K.; Welt, T.; Toschi, N.; Kaehler, S. T.; Singewald, N.; Philippu, A.; Elbel, G. K.; Wotjak, C. T. et al.; Holsboer, F.; Landgraf, R.; Engelmann, M.: Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amono acids in the rat brain. European Journal of Neuroscience 12, S. 3713 - 3720 (2000)

Müller, M. B.; Landgraf, R.; Preil, J.; Sillaber, I.; Kresse, A. E.; Keck, M. E.; Zimmermann, S.; Holsboer, F.; Wurst, W.: Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141, S. 4262 - 4269 (2000)

Azzi, M.; Betancur, C.; Sillaber, I.; Spanagel, R.; Rostène, W.; Bérod, A.: Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulated mesocortical and mesolimbic dopaminergic systems. Journal of Neurochemistry 71, S. 1158 - 1167 (1998)

Sillaber, I.; Montkowski, A.; Landgraf, R.; Barden, N.; Holsboer, F.; Spanagel, R.: Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide. Neuroscience 85, S. 415 - 425 (1998)

Spanagel, R.; Sillaber, I.; Zieglgänsberger, W.; Corrigall, W. A.; Stewart, J.; Shaham, Y.: Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139, S. 391 - 401 (1998)

Timpl, P.; Spanagel, R.; Sillaber, I.; Kresse, A.; Reul, J. M. H. M.; Stalla, G. K.; Blanquet, V.; Steckler, T.; Holsboer, F.; Wurst, W.: Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics 19, S. 162 - 166 (1998)